CHLA joins national consortium to study treatments for rare cardiac defect
Children’s Hospital Los Angeles is participating in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect that leaves them … Read More »